Geneva, Switzerland, Monday 6th October 2014 - DRIVE-AB (Driving Reinvestment in R&D and Responsible Antibiotic Use), a public-private consortium funded by the EU Innovative Medicines Initiative (IMI), was delighted to hold its inaugural meeting which announced the launch of a €9.3million project to tackle the dual crisis of antimicrobial resistance and re-stimulate Pharma interest in antibiotic research and development. Antimicrobial resistance (AMR).
Through a series of plenary discussions and break out sessions the expert consortium looked at work plans for delivering new economic models for antibiotic discovery and development and evaluation of the responsible use of new and old...
Read more
DRIVE-AB KICK START MEETING
